ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

0HD2 Alnylam Pharmaceuticals Inc

100.80
0.00 (0.00%)
Jun 13 2024 - Closed
Delayed by 15 minutes

Alnylam Pharmaceuticals Financial Summary

The current 0HD2 market cap is 12.65B. The company's latest EPS is USD -3.5081 and P/E is -45.72.

Year End December 30 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 219.75M492.85M844.29M1.04B1.83B
Operating Income -939.43M-828.44M-708.65M-785.07M-282.18M
Net Income -886.12M-858.28M-852.82M-1.13B-440.24M
Year End December 30 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 2.4B3.41B3.64B3.55B3.83B
Total Liabilities 956.44M2.39B3.06B3.7B4.05B
Total Equity 1.44B1.02B588.2M-158.22M-220.64M

Cash Flow

Year End December 30 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Operating -278.43M-614.96M-641.69M-541.27M104.16M
Investing -417.68M-435.52M-273.3M169.35M-336.35M
Financing 823.18M994.98M1.25B425.75M172.13M
Market Cap 12.65B
Price to Earnings Ratio -45.72
Price to Sales Ratio 11.01
Price to Cash Ratio 24.77
Price to Book Ratio -91.22
Dividend Yield -

Share Statistics

Shares Outstanding 125.49M
Average Volume (1 week) 288
Average Volume (1 Month) 254
52 Week Change 0.00%
52 Week High 100.80
52 Week Low 100.80
Spread (Intraday) 0 (0%)

Company Info

Company Name Alnylam Pharmaceuticals Inc
Address 1209 orange street
wilmington, delaware 19801
Website https://www.alnylam.com
Industry pharmaceutical preparations (2834)